embecta to Participate in Upcoming Investor Conferences

PARSIPPANY, N.J., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today announced that management will participate in the following upcoming investor conferences:

2023 BTIG Medical Technology Conference

• Management will host virtual investor meetings on Wednesday, February 15, 2023.

2023 JP Morgan Global High Yield and Leveraged Finance Conference

• Management will host a presentation session on Monday, March 6, 2023, at 2:00 p.m. Eastern Time (ET) in Miami, FL.

2023 Oppenheimer 33rd Annual Healthcare Conference

• Management will host a virtual presentation session on Tuesday, March 14, 2023, at 8:00 a.m. ET. Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company's investor relations website at investors.embecta.com.

About embecta embecta is one of the largest pure-play diabetes care companies in the world, leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of more than 2,000 employees around the globe. For more information, visit embecta.com.

CONTACTS 

Investors:Pravesh KhandelwalVP, Head of Investor Relations551-264-6547Contact IR

Media: Christian GlazarSr. Director, Corporate Communications 908-821-6922 Contact Media Relations 

You May Also Be Interested In

• Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Embecta Corp. (NASDAQ: EMBC); Navan, Inc. (NASDAQ: NAVN); and Power Solutions International, I
• RoboStrategy, Inc. Updates Net Asset Value as of June 22, 2026
• ESET takes part in global Operation Endgame to disrupt Amadey botnet and Stealc infostealer